Remember screening vs. diagnostic rules when billing colonoscopies

Why This Topic Matters

Correctly distinguishing screening from diagnostic services can affect patient cost-sharing, claim acceptance, and denial risk. The article helps practices understand the general billing context for colorectal cancer testing and why front-end claim handling matters.

Article Sections

1. Billing trends and denial patterns

   This section discusses claim volume patterns for colorectal cancer screening and diagnostic services and summarizes denial activity seen in claims data. It provides general context for why these services are frequently billed and denied.

2. Billing tips to avoid colon cancer claim denials

   This section covers broad billing considerations tied to symptom status, patient risk status, and Medicare frequency limits for colorectal cancer services. It also addresses when a screening claim may need to be treated differently after a procedure changes from preventive to diagnostic.